Total Payments
$351,375
2024 Payments
$669.81
Companies
59
Transactions
501
Medicare Patients
4,353
Medicare Billing
$420,564
Payment Breakdown by Category
Research$339,114 (96.5%)
Food & Beverage$8,472 (2.4%)
Consulting$3,000 (0.9%)
Travel$736.84 (0.2%)
Education$52.59 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $339,114 | 19 | 96.5% |
| Food and Beverage | $8,472 | 475 | 2.4% |
| Consulting Fee | $3,000 | 2 | 0.9% |
| Travel and Lodging | $736.84 | 2 | 0.2% |
| Education | $52.59 | 3 | 0.0% |
Payments by Type
Research
$339,114
19 transactions
General
$12,261
482 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Glenmark Pharmaceuticals Inc. | $336,114 | 18 | $0 (2018) |
| OptiNose US, Inc. | $3,272 | 13 | $0 (2020) |
| Lupin Inc. | $3,000 | 1 | $0 (2018) |
| Merck Sharp & Dohme Corporation | $1,174 | 17 | $0 (2021) |
| GlaxoSmithKline, LLC. | $915.94 | 66 | $0 (2023) |
| CSL Behring | $863.79 | 48 | $0 (2024) |
| Novo Nordisk Inc | $478.78 | 32 | $0 (2020) |
| AstraZeneca Pharmaceuticals LP | $476.72 | 24 | $0 (2023) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $440.05 | 29 | $0 (2021) |
| kaleo, Inc. | $353.34 | 14 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $669.81 | 23 | Jubilant HollisterStier LLC ($193.46) |
| 2023 | $641.04 | 44 | GlaxoSmithKline, LLC. ($150.42) |
| 2022 | $1,077 | 60 | GlaxoSmithKline, LLC. ($153.16) |
| 2021 | $943.22 | 60 | Octapharma USA, Inc. ($80.07) |
| 2020 | $532.08 | 33 | Novo Nordisk Inc ($185.55) |
| 2019 | $1,552 | 99 | Novo Nordisk Inc ($255.86) |
| 2018 | $245,355 | 91 | Glenmark Pharmaceuticals Inc. ($236,856) |
| 2017 | $100,606 | 91 | Glenmark Pharmaceuticals Inc. ($99,258) |
All Payment Transactions
501 individual payment records from CMS Open Payments — Page 1 of 21
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/19/2024 | Abbott Laboratories | ETERNA (Device) | Food and Beverage | In-kind items and services | $19.27 | General |
| Category: Neuromodulation | ||||||
| 11/13/2024 | CSL Behring | Haegarda (Biological) | Food and Beverage | In-kind items and services | $15.45 | General |
| Category: Immunology | ||||||
| 11/04/2024 | CSL Behring | Privigen (Biological), Hizentra | Food and Beverage | In-kind items and services | $24.45 | General |
| Category: Immunology | ||||||
| 10/29/2024 | Jubilant HollisterStier LLC | — | Food and Beverage | In-kind items and services | $193.46 | General |
| 10/08/2024 | CSL Behring | Hizentra (Biological), Privigen | Food and Beverage | In-kind items and services | $16.09 | General |
| Category: Immunology | ||||||
| 09/04/2024 | Nevro Corp. | Senza (Device) | Food and Beverage | In-kind items and services | $23.03 | General |
| Category: Spinal Cord Stimulator | ||||||
| 08/29/2024 | CSL Behring | Hizentra (Biological), Privigen | Food and Beverage | In-kind items and services | $17.88 | General |
| Category: Immunology | ||||||
| 08/26/2024 | Xeris Pharmaceuticals, Inc. | RECORLEV (Drug) | Food and Beverage | In-kind items and services | $21.39 | General |
| Category: Adrenal steroidogenesis inhibitor | ||||||
| 07/18/2024 | Blueprint Medicines Corporation | AYVAKIT (Drug) | Food and Beverage | Cash or cash equivalent | $20.32 | General |
| Category: Oncology / Rare Diseases | ||||||
| 06/26/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $29.43 | General |
| Category: Endocrinology | ||||||
| 06/24/2024 | CSL Behring | Haegarda (Biological) | Food and Beverage | In-kind items and services | $20.77 | General |
| Category: Immunology | ||||||
| 06/04/2024 | Xeris Pharmaceuticals, Inc. | GVOKE HYPOPEN (Drug) | Food and Beverage | In-kind items and services | $29.77 | General |
| Category: Diabetes | ||||||
| 04/30/2024 | Xeris Pharmaceuticals, Inc. | GVOKE HYPOPEN (Drug) | Food and Beverage | In-kind items and services | $25.35 | General |
| Category: Diabetes | ||||||
| 04/29/2024 | Blueprint Medicines Corporation | AYVAKIT (Drug) | Food and Beverage | Cash or cash equivalent | $25.44 | General |
| Category: Oncology / Rare Diseases | ||||||
| 04/23/2024 | Tandem Diabetes Care, Inc. | t:slim X2 Insulin Pump with Control-IQ (Device) | Food and Beverage | In-kind items and services | $18.26 | General |
| Category: Endocrinology | ||||||
| 03/28/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $20.58 | General |
| Category: Endocrinology | ||||||
| 03/06/2024 | Novartis Pharmaceuticals Corporation | XOLAIR (Drug) | Food and Beverage | In-kind items and services | $18.72 | General |
| Category: Pulmonary/Respiratory Diseases | ||||||
| 02/26/2024 | Blueprint Medicines Corporation | AYVAKIT (Drug) | Food and Beverage | Cash or cash equivalent | $27.09 | General |
| Category: Oncology / Rare Diseases | ||||||
| 01/31/2024 | HOSPIRA, INC. | OCTAGAM IMMUNE GLOBULIN (HUMAN) (Drug), PANZYGA, CUTAQUIG | Food and Beverage | In-kind items and services | $17.73 | General |
| Category: IMMUNOLOGY | ||||||
| 01/22/2024 | Novartis Pharmaceuticals Corporation | XOLAIR (Drug) | Food and Beverage | In-kind items and services | $18.46 | General |
| Category: Pulmonary/Respiratory Diseases | ||||||
| 01/18/2024 | Mannkind Corporation | AFREZZA (Drug) | Food and Beverage | In-kind items and services | $21.35 | General |
| Category: DIABETES MEDICINE | ||||||
| 01/09/2024 | Radius Health, Inc. | Tymlos (Drug) | Food and Beverage | In-kind items and services | $21.32 | General |
| Category: Endocrinology | ||||||
| 01/04/2024 | Corcept Therapeutics | Korlym (Drug) | Food and Beverage | In-kind items and services | $24.20 | General |
| Category: Endocrinology | ||||||
| 12/07/2023 | MannKind Corporation | AFREZZA (Drug) | Food and Beverage | In-kind items and services | $18.33 | General |
| Category: DIABETES MEDICINE | ||||||
| 12/04/2023 | Corcept Therapeutics | Korlym (Drug) | Food and Beverage | In-kind items and services | $15.04 | General |
| Category: Endocrinology | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| GSP301-304 | Glenmark Pharmaceuticals Inc. | $63,458 | 7 |
| GSP 301-303 | Glenmark Pharmaceuticals Inc. | $35,800 | 5 |
| A RANDOMIZED, DOUBLE-BLIND, DOUBLE-DUMMY, PLACEBO-CONTROLLED, PARALLEL-GROUP, MULTICENTER CLINICAL STUDY TO ASSESS THE EFFICACY AND SAFETY OF TWICE DAILY ADMINISTRATION OF FLUTICASONE PROPIONATE 100 MCG AND SALMETEROL XINAFOATE 50 MCG DRY POWDER INHALER COMPARED TO ADMINISTRATION WITH ADVAIR DISKUS 10050 MCG TWICE DAILY AND PLACEBO IN PATIENTS 12 YEARS OF AGE AND OLDER WITH REVERSIBLE PERSISTENT ASTHMA INCLUDING A 3-WEEK OPEN-LABEL EXTENSION TO ASSESS INHALER ROBUSTNESS | Lupin Inc. | $3,000 | 1 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 17 | 1,019 | 10,286 | $290,167 | $97,161 |
| 2022 | 14 | 1,040 | 11,054 | $307,216 | $105,719 |
| 2021 | 16 | 1,158 | 12,474 | $339,950 | $119,857 |
| 2020 | 15 | 1,136 | 11,028 | $310,175 | $97,827 |
Total Patients
4,353
Total Services
44,842
Medicare Billing
$420,564
Procedure Codes
62
All Medicare Procedures & Services
62 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 95165 | Professional service for preparation and provision of 1 or more antigens | Office | 2023 | 170 | 2,206 | $61,768 | $21,475 | 34.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 126 | 208 | $33,370 | $17,746 | 53.2% |
| 95115 | Professional service for single injection of allergen | Office | 2023 | 112 | 1,843 | $49,761 | $12,006 | 24.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 154 | 203 | $24,360 | $11,444 | 47.0% |
| 95004 | Test for allergy using allergenic extract | Office | 2023 | 65 | 4,133 | $45,463 | $11,426 | 25.1% |
| 95117 | Professional service for multiple injections of allergen | Office | 2023 | 68 | 1,267 | $41,811 | $9,686 | 23.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 34 | 34 | $8,500 | $3,399 | 40.0% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 41 | 41 | $3,275 | $2,946 | 89.9% |
| 94010 | Test to measure expiratory airflow and volume | Office | 2023 | 84 | 138 | $11,040 | $2,576 | 23.3% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 42 | 42 | $1,455 | $1,239 | 85.2% |
| 87811 | Detection test by immunoassay with direct visual observation for severe acute respiratory syndrome coronavirus 2 (covid-19) | Office | 2023 | 21 | 23 | $1,605 | $913.90 | 56.9% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Office | 2023 | 25 | 26 | $3,380 | $730.50 | 21.6% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 13 | 13 | $1,885 | $704.08 | 37.4% |
| 87804 | Detection test by immunoassay with direct visual observation for influenza virus | Office | 2023 | 11 | 21 | $588.00 | $340.62 | 57.9% |
| 95024 | Test for allergy using allergenic extract injected into skin | Office | 2023 | 13 | 46 | $598.00 | $276.99 | 46.3% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 24 | 26 | $988.00 | $238.92 | 24.2% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 16 | 16 | $320.00 | $11.15 | 3.5% |
| 95165 | Professional service for preparation and provision of 1 or more antigens | Office | 2022 | 175 | 2,401 | $67,228 | $24,177 | 36.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 156 | 257 | $41,210 | $22,245 | 54.0% |
| 95004 | Test for allergy using allergenic extract | Office | 2022 | 74 | 4,589 | $50,479 | $13,532 | 26.8% |
| 95115 | Professional service for single injection of allergen | Office | 2022 | 121 | 2,016 | $54,432 | $12,620 | 23.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 157 | 195 | $23,400 | $11,582 | 49.5% |
| 95117 | Professional service for multiple injections of allergen | Office | 2022 | 65 | 1,242 | $40,986 | $9,396 | 22.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 35 | 35 | $8,750 | $3,914 | 44.7% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 49 | 49 | $3,655 | $3,345 | 91.5% |
About Dr. Niran Amar, M.D
Dr. Niran Amar, M.D is a Clinical & Laboratory Immunology healthcare provider based in Waco, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/21/2005. The National Provider Identifier (NPI) number assigned to this provider is 1003812595.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Niran Amar, M.D has received a total of $351,375 in payments from pharmaceutical and medical device companies, with $669.81 received in 2024. These payments were reported across 501 transactions from 59 companies. The most common payment nature is "" ($339,114).
As a Medicare-enrolled provider, Amar has provided services to 4,353 Medicare beneficiaries, totaling 44,842 services with total Medicare billing of $420,564. Data is available for 4 years (2020–2023), covering 62 distinct procedure/service records.
Ad
Practice Information
- Specialty Clinical & Laboratory Immunology
- Other Specialties Allergy & Immunology
- Location Waco, TX
- Active Since 06/21/2005
- Last Updated 12/27/2021
- Taxonomy Code 207KI0005X
- Entity Type Individual
- NPI Number 1003812595
Products in Payments
- Xhance (Drug) $3,272
- ADVAIR (Drug) $3,000
- DULERA (Drug) $1,000
- Hizentra (Biological) $465.11
- Haegarda (Biological) $359.04
- Ozempic (Drug) $303.36
- JARDIANCE (Drug) $287.10
- NUCALA (Biological) $283.72
- SYMBICORT (Drug) $281.93
- TRELEGY ELLIPTA (Drug) $276.52
- Auvi-Q (Drug) $276.45
- CUTAQUIG (Biological) $221.17
- BREO (Drug) $215.71
- DUPIXENT (Biological) $193.43
- EUCRISA (Drug) $175.25
- Yupelri (Drug) $154.77
- Vascepa (Drug) $148.75
- Kerendia (Drug) $143.85
- DUPIXENT (Drug) $143.10
- JANUVIA (Drug) $142.94
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.